SMS Lifesciences India Limited (NSE:SMSLIFE)
India
· Delayed Price · Currency is INR 1,310.30
-14.90 (-1.12%)
Apr 30, 2025, 3:29 PM IST
SMS Lifesciences India Revenue
SMS Lifesciences India had revenue of 846.01M INR in the quarter ending December 31, 2024, with 17.41% growth. This brings the company's revenue in the last twelve months to 3.46B, up 23.56% year-over-year. In the fiscal year ending March 31, 2024, SMS Lifesciences India had annual revenue of 3.06B, down -3.04%.
Revenue (ttm)
3.46B
Revenue Growth
+23.56%
P/S Ratio
1.15
Revenue / Employee
6.02M
Employees
574
Market Cap
3.96B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |